FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3089351104> ?p ?o ?g. }

• W3089351104 endingPage "3345" @default.
• W3089351104 startingPage "3337" @default.
• W3089351104 abstract "Background The establishment of biomarkers that can be used to predict the response to immunotherapy for malignancy is extremely important. In particular, noninvasive analysis of immune cells from peripheral blood before treatment has gained increased attention, and natural killer (NK) cell activity has been shown to be related to treatment response. Here, we aimed to confirm the relationship between the response to immunotherapy and NK cell activity. Methods In this prospective observational study, patients with advanced NSCLC who were scheduled for immunotherapy from October 2018 to December 2019 were enrolled. Baseline NK cell activity was compared according to the best clinical response to immunotherapy. Results A total of 54 patients with advanced NSCLC were enrolled, and 34 patients were analyzed. The baseline NK cell activity was significantly higher in the non‐PD group than in the PD group ( P = 0.002). At the cutoff level of ≥1200 pg/mL, baseline NK cell activity yielded a sensitivity of 80% and a specificity of 68.4% in predicting the response to immunotherapy (AUC = 0.8, P < 0.003). The median progression‐free survival (PFS) was significantly better in the high NK group ( P = 0.003), and correlation between baseline NK cell activity and PFS was also confirmed (r = 0.517, P = 0.002). Conclusions Baseline NK cell activity was related to the response to immunotherapy and the PFS. We suggest that NK cell activity from peripheral blood before immunotherapy is a noninvasive, simple, and novel way to predicting the treatment response in patients with NSCLC. Key points Significant findings of the study The response to immunotherapy was significantly better in patients with high baseline NK cell activity, and there was a significant correlation between baseline NK cell activity and PFS. What this study adds This study demonstrates the efficacy of baseline NK cell activity from peripheral blood as a biomarker for predicting immunotherapy response." @default.
• W3089351104 created "2020-10-08" @default.
• W3089351104 creator A5008146677 @default.
• W3089351104 creator A5035052771 @default.
• W3089351104 creator A5041035234 @default.
• W3089351104 creator A5067969008 @default.
• W3089351104 creator A5078295866 @default.
• W3089351104 date "2020-10-05" @default.
• W3089351104 modified "2023-10-18" @default.
• W3089351104 title "Efficacy of natural killer cell activity as a biomarker for predicting immunotherapy response in non‐small cell lung cancer" @default.
• W3089351104 cites W1982488143 @default.
• W3089351104 cites W2014229457 @default.
• W3089351104 cites W2066671159 @default.
• W3089351104 cites W2100158834 @default.
• W3089351104 cites W2104347254 @default.
• W3089351104 cites W2106511606 @default.
• W3089351104 cites W2122639773 @default.
• W3089351104 cites W2136859769 @default.
• W3089351104 cites W2139072868 @default.
• W3089351104 cites W2143488876 @default.
• W3089351104 cites W2156353875 @default.
• W3089351104 cites W2198093519 @default.
• W3089351104 cites W2402433991 @default.
• W3089351104 cites W2554618897 @default.
• W3089351104 cites W2559382297 @default.
• W3089351104 cites W2625684877 @default.
• W3089351104 cites W2737656823 @default.
• W3089351104 cites W2739338441 @default.
• W3089351104 cites W2800568511 @default.
• W3089351104 cites W2883706035 @default.
• W3089351104 cites W2888408613 @default.
• W3089351104 cites W2890056446 @default.
• W3089351104 cites W2893388531 @default.
• W3089351104 cites W2897222331 @default.
• W3089351104 cites W2902771169 @default.
• W3089351104 cites W2903686952 @default.
• W3089351104 cites W2909679049 @default.
• W3089351104 cites W2948843630 @default.
• W3089351104 cites W2990052644 @default.
• W3089351104 cites W3006514782 @default.
• W3089351104 cites W3011381420 @default.
• W3089351104 cites W3015453478 @default.
• W3089351104 doi "https://doi.org/10.1111/1759-7714.13677" @default.
• W3089351104 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7606014" @default.
• W3089351104 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33017518" @default.
• W3089351104 hasPublicationYear "2020" @default.
• W3089351104 type Work @default.
• W3089351104 sameAs 3089351104 @default.
• W3089351104 citedByCount "11" @default.
• W3089351104 countsByYear W30893511042021 @default.
• W3089351104 countsByYear W30893511042022 @default.
• W3089351104 countsByYear W30893511042023 @default.
• W3089351104 crossrefType "journal-article" @default.
• W3089351104 hasAuthorship W3089351104A5008146677 @default.
• W3089351104 hasAuthorship W3089351104A5035052771 @default.
• W3089351104 hasAuthorship W3089351104A5041035234 @default.
• W3089351104 hasAuthorship W3089351104A5067969008 @default.
• W3089351104 hasAuthorship W3089351104A5078295866 @default.
• W3089351104 hasBestOaLocation W30893511041 @default.
• W3089351104 hasConcept C126322002 @default.
• W3089351104 hasConcept C143998085 @default.
• W3089351104 hasConcept C1491633281 @default.
• W3089351104 hasConcept C154317977 @default.
• W3089351104 hasConcept C202751555 @default.
• W3089351104 hasConcept C203014093 @default.
• W3089351104 hasConcept C2776256026 @default.
• W3089351104 hasConcept C2777701055 @default.
• W3089351104 hasConcept C2778102761 @default.
• W3089351104 hasConcept C2781197716 @default.
• W3089351104 hasConcept C54355233 @default.
• W3089351104 hasConcept C55493867 @default.
• W3089351104 hasConcept C71924100 @default.
• W3089351104 hasConcept C86803240 @default.
• W3089351104 hasConcept C8891405 @default.
• W3089351104 hasConceptScore W3089351104C126322002 @default.
• W3089351104 hasConceptScore W3089351104C143998085 @default.
• W3089351104 hasConceptScore W3089351104C1491633281 @default.
• W3089351104 hasConceptScore W3089351104C154317977 @default.
• W3089351104 hasConceptScore W3089351104C202751555 @default.
• W3089351104 hasConceptScore W3089351104C203014093 @default.
• W3089351104 hasConceptScore W3089351104C2776256026 @default.
• W3089351104 hasConceptScore W3089351104C2777701055 @default.
• W3089351104 hasConceptScore W3089351104C2778102761 @default.
• W3089351104 hasConceptScore W3089351104C2781197716 @default.
• W3089351104 hasConceptScore W3089351104C54355233 @default.
• W3089351104 hasConceptScore W3089351104C55493867 @default.
• W3089351104 hasConceptScore W3089351104C71924100 @default.
• W3089351104 hasConceptScore W3089351104C86803240 @default.
• W3089351104 hasConceptScore W3089351104C8891405 @default.
• W3089351104 hasIssue "11" @default.
• W3089351104 hasLocation W30893511041 @default.
• W3089351104 hasLocation W30893511042 @default.
• W3089351104 hasOpenAccess W3089351104 @default.
• W3089351104 hasPrimaryLocation W30893511041 @default.
• W3089351104 hasRelatedWork W1967103478 @default.
• W3089351104 hasRelatedWork W1996150995 @default.
• W3089351104 hasRelatedWork W2032912323 @default.
• W3089351104 hasRelatedWork W2140647949 @default.

• next